7498 Results (Page 234 of 300)
Pharmaceuticals Markets Research Reports
France Cardiovascular Diseases Therapeutics Market Analysis
France's cardiovascular disease therapeutics market is projected to grow from $4.47 Bn in 2022 to $7.24 Bn in 2030 with a CAGR of 6.22% for the year 2022-2030. The rising prevalence of cardiovascular diseases in France and consequently increased healthcare spending in France are the major market drivers for the growth of the market. The France cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Medac, Laboratoires Boiron, and AstraZeneca are the major players in the France cardiovascular disease therapeutics market.
China Cardiovascular Diseases Therapeutics Market Analysis
China's cardiovascular disease therapeutics market is expected to witness growth from $13.07 Bn in 2022 to $25.52 Bn in 2030 with a CAGR of 8.72% for the year 2022-30. The shifting lifestyle modifications in China have led to an increase in the prevalence of cardiovascular diseases, therefore, driving the growth of the market. The China cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Lanrui Boyan Medical, Beijing Handian Pharmacy, and AstraZeneca are the major players in the China cardiovascular disease therapeutics market.
Brazil Cardiovascular Diseases Therapeutics Market Analysis
Brazil's cardiovascular disease therapeutics market is expected to witness growth from $4.06 Bn in 2022 to $7.64 Bn in 2030 with a CAGR of 8.22% for the forecasted year 2022-2030 due to the rising geriatric population and their subsequent demand for new and innovative therapeutic options in Brazil are responsible for the growth of the market. The Brazil cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Eurofarma, Cálamo Distribuidora, and Pfizer are the major players in the Brazil cardiovascular disease therapeutics market.
Tanzania Anti Aging Therapeutics Market Analysis
Tanzania anti-aging therapeutics market is projected to witness growth from $0 Mn in 2022 to $1 Mn in 2030 with a CAGR of 17.43% for the year 2022-2030. The rise in the aging population in Tanzania and the supportive regulatory initiatives taken by the Tanzanian government are the major market drivers for the growth of the market. The Tanzania anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Nashukuru Pharma, Arwa Pharmacy, and Intervene Immune are the key players in the market.
Turkey Anti Aging Therapeutics Market Analysis
Turkey anti-aging therapeutics market is projected to grow from $5 Mn in 2022 to $17 Mn in 2030 with a CAGR of 17.03% for the year 2022-2030. The emerging development and increased efforts in research for stem cell therapy in Turkey as well as rising disposable incomes in Turkey are responsible for the expansion of the market. The Turkey anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the leading players in the market are Gene2info, Turgut Pharmaceuticals, and Biosplice.
India Anti Aging Therapeutics Market Analysis
India anti-aging therapeutics market is expected to witness growth from $11 Mn in 2022 to $46 Mn in 2030 with a CAGR of 19.53% for the year 2022-2030. The growth from the baby boomer population to the middle age population in India and their subsequent demand for ant-aging products for a more youthful appearance are the major market drivers. The India anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Glenmark, Navitor Pharmaceuticals, and NeuroTrack are some of the key players in the market.
Kenya Anti Aging Therapeutics Market Analysis
Kenya anti-aging therapeutics market is projected to witness growth from $0 Mn in 2022 to $2 Mn in 2030 with a CAGR of 17.63% for the year 2022-2030. The rising economy of Kenya as well as the growing awareness about the various anti-aging therapeutic options in Kenya are responsible for the expansion of the market. The Kenya anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key competitors in the market are Comet Healthcare, Cosmos, and Cambrian Biopharma.
UAE Anti Aging Therapeutics Market Analysis
UAE anti-aging therapeutics market is projected to grow from $3 Mn in 2022 to $11 Mn in 2030 with a CAGR of 17.53% for the year 2022-2030. The market is projected to expand as a result of the growing demand for anti-aging treatments and rising disposable incomes in the UAE. The UAE anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Insilico Medicine, Kuwait Saudi Pharmaceuticals, and Alkahest are the top players in the market.
Egypt Anti Aging Therapeutics Market Analysis
Egypt anti-aging therapeutics market is expected to witness growth from $2 Mn in 2022 to $6 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. Egypt’s rising elderly population and their subsequent demand for innovative anti-aging treatments are responsible for the growth of the market during the forecast period. The Egypt anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the leading players in the market are CEB, Botogenix, and Intervene Immune.
Italy Anti Aging Therapeutics Market Analysis
Italy anti-aging therapeutics market is expected to witness growth from $14 Mn in 2022 to $48 Mn in 2030 with a CAGR of 16.03% for the year 2022-2030. The rising awareness about age-related disorders among the Italian population and growing investments in anti-aging treatments in Italy by major biotechnology companies are driving the growth of the market. The Italy anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Recipharm, Italfarmaco, and Cambrian Biopharma are among the leading players in the market.
France Anti Aging Therapeutics Market Analysis
France anti-aging therapeutics market is expected to witness growth from $17 Mn in 2022 to $53 Mn in 2030 with a CAGR of 15.53% for the year 2022-2030. The presence of robust research and development industry in France makes it a popular destination for the testing of anti-aging therapeutics thereby resulting in the growth of the market. The France anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key players in the market include Cottos, DBV Technologies, and Allergan.
Spain Anti Aging Therapeutics Market Analysis
Spain anti-aging therapeutics market is projected to grow from $12 Mn in 2022 to $37 Mn in 2030 with a CAGR of 15.53% for the year 2022-2030. The rise in the aging population in Spain and the increase in affordability of the newer treatment option owing to the growing economy in Spain are the major market drivers. The Spain anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key players in the market are IDP Pharma, Oryzon Genomics, and Allergan.
UK Anti Aging Therapeutics Market Analysis
UK anti-aging therapeutics market is projected to grow from $16 Mn in 2022 to $46 Mn in 2030 with a CAGR of 14.53% for the year 2022-2030. The rising geriatric population, increasing demand for anti-aging therapeutics, and rising healthcare expenditure are the major market drivers for the growth of the market. The UK anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key players in the market include Veristat, Genflow Biosciences, and Regenerative Medicine.
Japan Anti Aging Therapeutics Market Analysis
Japan anti-aging therapeutics market is projected to grow from $38 Mn in 2022 to $132 Mn in 2030 with a CAGR of 17.03% for the year 2022-2030. Japan has the fastest-growing geriatric population which results in increased demand for anti-aging treatments. Further, in Japan, there is the presence of highly advanced technology which results in the expansion of the market. The Japan anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Modulus Discovery, Noile-Immune Biotech, and NeuroTrack are some of the top players in the market.
Netherlands Anti Aging Therapeutics Market Analysis
Netherlands anti-aging therapeutics market is projected to grow from $2 Mn in 2022 to $6 Mn in 2030 with a CAGR of 17.03% for the year 2022-2030. Technological advancements in the form of new and inventive therapeutics in the Netherlands as well as increased R&D efforts in the Netherlands are responsible for the market expansion. The Netherlands anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. KEI Biotechnology, AHV International, and Biosplice are the major players in the market.
Belgium Anti Aging Therapeutics Market Analysis
Belgium anti-aging therapeutics market is expected to witness growth from $1 Mn in 2022 to $5 Mn in 2030 with a CAGR of 16.53% for the forecasted year 2022-2030 due to the rising geriatric population and the emergence of novel and more advanced therapeutic options for anti-aging in Belgium. The Belgium anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Bioxodes, Biotalys, and Elysium Health are some of the leading companies in Belgium anti-aging therapeutics market.
Mexico Anti Aging Therapeutics Market Analysis
Mexico anti-aging therapeutics market is projected to grow from $9 Mn in 2022 to $31 Mn in 2030 with a CAGR of 16.78% for the year 2022-2030. The rising elderly population and increasing awareness about anti-aging treatments are the major factors responsible for the growth of the market. The Mexico anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Novastem, Liventia, and ENDYMED are some of the key competitors in the market.
Philippines Anti Aging Therapeutics Market Analysis
Philippines anti-aging therapeutics market is projected to grow from $1 Mn in 2022 to $5 Mn in 2030 with a CAGR of 17.03% for the year 2022-2030. The increase in disposable incomes and more investments in the R&D projects for anti-aging drugs in Philippines are the major growth drivers of the market. The Philippines anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Distriphil, PHIX Genomics, and Rejuvenate Bio are among the top players in the market.
Nigeria Anti Aging Therapeutics Market Analysis
Nigeria anti-aging therapeutics market is expected to witness growth from $1 Mn in 2022 to $2 Mn in 2030 with a CAGR of 17.53% for the forecasted year 2022-2030 due to the increase in age-related chronic disorders and the rise in awareness about anti-aging therapeutics in Nigeria. The Nigeria anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the major players in the market are May and Baker, Agary Pharmaceutical, and Athersys.
South Africa Anti Aging Therapeutics Market Analysis
South Africa anti-aging therapeutics market is expected to witness growth from $4 Mn in 2022 to $15 Mn in 2030 with a CAGR of 17.76% for the year 2022-2030. Major market drivers for the market include rising elderly population and growing awareness about anti-aging therapeutics in South Africa. The South Africa anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Thermo Fisher Scientific, Inqaba Biotechnical Industries, and Intervene Immune are some of the key players in the market.
Romania Anti Aging Therapeutics Market Analysis
Romania anti-aging therapeutics market is projected to grow from $2 Mn in 2022 to $6 Mn in 2030 with a CAGR of 16.78% for the year 2022-2030. The growing economy in Romania and supportive government policies for increased R&D investments in anti-aging therapeutics in Romania are responsible for the growth of the market. The Romania anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the major players in the market include Leciva Slovakofarma, ICCF, and Mitobridge.
Canada Liver Cancer Therapeutics Market Analysis
Canada's liver cancer therapeutics market is likely to grow at a CAGR of 17.6% from a market size of $234 Mn in 2022 to $857 Mn in 2030. The increase in awareness among the people regarding the disease and the increasing prevalence of the disease drives the market growth This report is segmented by treatment, type, equipment, route of administration, and the end user. Some key players in this market include Bayer, Bristol-Myers & Squibb, Pfizer, Merck, Roche, Eli Lilly, and others.
South Korea Anti Aging Therapeutics Market Analysis
South Korea anti-aging therapeutics market is projected to grow from $9 Mn in 2022 to $32 Mn in 2030 with a CAGR of 17.53% for the year 2022-2030. Presence of advanced technologies and increases research and development initiatives in South Korea is responsible for the expansion of the market. The South Korea anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the leading companies in the market include Hanmi Pharmaceuticals, SK Bioscience, and Merz Pharma.
South Africa ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
South Africa's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $192 Mn in 2022 to $375 Mn in 2030 with a CAGR of 8.73% for the year 2022-2030. The rise in the incidence of ADHD cases in South Africa and increasing urbanization are the major growth drivers of the market. The South Africa ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Mirren, Phend Pharma, and Noven Pharmaceuticals are the key competitors in the market.
Romania ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Romania's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $86 Mn in 2022 to $156 Mn in 2030 with a CAGR of 7.75% for the year 2022-2030. The rising rate of ADHD in Romania and consequently the increasing demand for its therapeutic options are driving the growth of the market. The Romania ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Sun Wave Pharma, Oftafarma Romania, and Prude Pharma are some of the key players in the market.
